Kailera Therapeutics (NASDAQ:KLRA) Director Adam Koppel Purchases 1,562,500 Shares of Stock

Kailera Therapeutics, Inc. (NASDAQ:KLRA) Director Adam Koppel acquired 1,562,500 shares of the firm’s stock in a transaction on Monday, April 20th. The shares were bought at an average cost of $16.00 per share, with a total value of $25,000,000.00. Following the completion of the transaction, the director directly owned 22,583,268 shares in the company, valued at $361,332,288. This trade represents a 7.43% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Kailera Therapeutics Stock Performance

Shares of KLRA stock opened at $24.61 on Tuesday. Kailera Therapeutics, Inc. has a twelve month low of $23.69 and a twelve month high of $28.23.